Track topics on Twitter Track topics that are important to you
Forte publishes findings from recent survey on common challenges and practices in today’s research industry.
Madison, WI (PRWEB) June 29, 2017
Forte Research Systems, Inc., an industry-leading developer of specialized clinical research solutions, released the 2017 State of the Clinical Research Industry Report, with findings from their recent industry survey. This free report takes a look at challenges and practices in today’s research industry, as reported by over 900 survey participants.
Forte received survey responses from individuals across the country that work for a variety of organizations, including research sites, academic medical centers (AMC)s, Cancer Centers, health systems, sponsors, contract research organizations (CROs) and more. Through this project, they identified respondents’ key operational challenges and learned how their organizations are currently addressing these roadblocks.
New challenges in an evolving industry
In the report, Forte examines new challenges arising amid a continuous evolution in the way clinical trials are conducted. Some findings revealed commonalities in the amount of reported pain associated with particular tasks. For example, one survey participant cited study startup as a particular challenge, “Often we discover small issues with study requirements of which we were not aware during study acceptance and preparation. This brings study activation to a screeching halt."
Shree Kalluri, Forte’s CEO, Founder and Chief Customer Officer, stated, “a key part of improvement lies in understanding the problem.” Kalluri finds the survey data aligns with what Forte often hears from its customers about the need for collaborative solutions in clinical trials.
Centralization of systems is a key challenge Forte actively works to address and this issue was confirmed as a significant pain point for survey respondents. “Lack of centralization is a challenge at my organization. We currently have many systems that aren’t able to integrate with each other. Therefore, it is difficult to execute system wide communication, document storage and project updates,” a respondent reported.
Forte works closely with its customers and the larger research community to develop solutions for these foundational industry challenges. “In the past, systems were mostly built for recordkeeping purposes after the fact,” said Kalluri. “Now, we see systems enabling existing workflows and creating system-wide efficiencies by knocking down silos and sharing information between departments in real-time.”
Forte discloses further details about survey results in their report and explores:
Find out why Forte believes the need for solutions to address inefficiencies in research operations has never been more pertinent. Download a copy of the report at ForteResearch.com/resources.
Forte Research Systems, Inc. has been developing specialized solutions for clinical research since 2000. Forte solutions include OnCore Enterprise Research, Allegro CTMS, Forte EDC, Forte Research Evaluation System (EVAL) and Forte eRegulatory Management System (eReg).
In 2015, Forte launched a wholly-owned subsidiary, Nimblify Inc., to solve chronic problems and change the industry by connecting key stakeholders such as sponsors, CROs and research sites. Nimblify solutions include: Participant Payments, Clinical Operations Analytics Site Benchmarks and Research Insights and the Nimblify Marketplace which offers business operations solutions to help relieve administrative tasks so they expedite study activation and focus on the research and patients. Nimblify Marketplace services include Protocol Calendars, eCRF Builds and Coverage Analysis Certification.
Forte & Nimblify provide complimentary blog articles, eBooks, webinars and more to support continuous learning on industry topics. With a strong belief in community, collaboration and standards-based development, Forte also facilitates the Onsemble Community, which brings clinical research professionals together twice a year at the Onsemble Conference.
For the original version on PRWeb visit: http://www.prweb.com/releases/2017/06/prweb14471429.htmNEXT ARTICLE
Clinical Research Organization
Contract Research Organization (CRO) provide research services outsourced on a contract basis to the pharmaceutical, biotechnology, healthcare and medical device industries: biopharmaceutical development biologic assay development commercial...
Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...